Chronic Myeloid Leukemia Bcr-abl1-positive

• CLINICAL_TRIALS trial_result · 2024-12-12
  Clinical Trial Update: Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia [Phase 1]

  Phase 1 trial of fludarabine, cytarabine, and pegcrisantaspase for relapsed or refractory leukemias was terminated; the update notes the stu…

• CLINICAL_TRIALS trial_result · 2019-01-09
  Clinical Trial Update: Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia [Phase 2]

  Phase 2 trial investigating pioglitazone in combination with a tyrosine kinase inhibitor for relapsed chronic myeloid leukemia (BCR-ABL1 pos…